Standard Medical Treatments

Managing Mal de Meleda focuses on reducing the thickness of the skin and improving your daily comfort. Because this is a genetic condition, current medical treatments are symptomatic—meaning they control the symptoms rather than cure the underlying cause ^[1][2]. Most care plans involve a combination of topical creams and, for more extensive cases, oral medications.

Topical Keratolytics and Emollients

The first line of management usually involves applying products directly to the skin to soften and thin the thickened layers.

• Keratolytics: These are “skin-peeling” agents, such as urea and salicylic acid, that help break down the excess keratin ^[2][3]. While they are necessary to penetrate dense plaques, they must be used carefully under a clinician’s direction. Salicylic acid applied over large areas, under occlusive wraps, on broken skin, or in young children can cause systemic toxicity. Similarly, urea can cause intense stinging if applied to open cracks or inflamed skin ^[1]. Do not self-escalate the concentration of these products without your doctor’s guidance.
• Emollients: Frequent use of thick moisturizers (emollients) is essential to keep the skin flexible and prevent painful fissures ^[4].
• Topical Retinoids: In some cases, your doctor may prescribe topical versions of Vitamin A, such as tretinoin or tazarotene ^[5][6]. Note that tazarotene carries important pregnancy restrictions; discuss these with your prescriber.

Systemic Treatment: Oral Retinoids

For patients whose symptoms are not adequately controlled by topical therapies, systemic retinoids—oral medications derived from Vitamin A, such as acitretin—are an individualized, often off-label option ^[1][2].

Acitretin works by slowing down the rapid production of skin cells. Responses are highly variable: some patients experience improved range of motion and thinner plaques, while others see limited benefit or experience side effects that require stopping the medication ^[7][8]. Symptoms often recur if the medication is discontinued.

Strict Safety and Monitoring for Oral Retinoids

Acitretin is a high-risk medication that requires extensive supervision by a dermatologist and adherence to local regulatory programs.

• Teratogenicity (Pregnancy Risk): Acitretin causes severe birth defects and must never be used during pregnancy or breastfeeding. Because it stays in the body for a very long time, people who can become pregnant must participate in strict pregnancy prevention programs. This typically requires documented negative pregnancy tests and the use of two reliable forms of contraception before starting, during treatment, and for three years after the last dose ^[9][10].
• Alcohol Restrictions: Alcohol can cause acitretin to convert into a substance that stays in the body even longer. Patients must strictly avoid alcohol during treatment and for a specified period (often two months) afterward.
• Blood Donation: You cannot donate blood during treatment and for three years after stopping, to prevent the blood from being given to a pregnant person.
• Liver and Lipid Monitoring: These medications can affect liver function and increase blood fats (triglycerides and cholesterol). You will need regular blood tests ^[11][12].
• Skeletal Changes: Long-term use can sometimes lead to bone or ligament changes (hyperostosis). Routine X-rays are not required for everyone, but your doctor will individualize imaging based on your symptoms and treatment duration if you report new joint or back pain ^[13][14].
• Mucocutaneous Effects: Common side effects include very dry lips, dry eyes, and peeling skin ^[6][15].

Because clinical trials for Mal de Meleda are limited, many treatment recommendations are based on expert consensus ^[16]. Your care team will help you weigh the risks and benefits of these therapies based on your personal health goals.